ADPKD, the most common hereditary kidney disorder, is the fourth leading cause of ESKD and can cause life-threatening extrarenal manifestations. This program provides a comprehensive, case-based update on key aspects of ADPKD care, including the context of the 2025 KDIGO ADPKD guideline.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 7.5 credits
MOC types
No MOC
FDA REMS
No
Qualifies for MIPS
No
Start Date
October 21, 2026
End Date
October 22, 2026
Target Specialties
Address:
- 1401 H Street, NW, Suite 900
Pricing
CME included with membership
| ASN Member – KSAP access | Free |
| Non-Member – KSAP module | $200 |
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
- Live
- Credit · Up to 7.5 credits
- Paid · fee on provider site
-
WhenOct 21, 2026
-
National Kidney Foundation Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Focus: Guiding Practice Through the Latest KDIGO Guidelines
-
PRIME Education, Inc. (PRIME®) Entering a New Era of Opportunity for APOL1-Mediated Kidney Disease (AMKD): Connecting Genetic Screening to Clinical Trials for Breakthrough Therapies
-
Optum Health Education Chronic Kidney Disease: Advancing Strategies to Prevent Progression
